Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
115.50    0.00 (0.00%)
Bid:
115.50
Ask:
117.00
Spread: 1.50 (1.299%)
Market Cap: £255.31m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

Company Update Presentation

27 Apr 2021 07:00

RNS Number : 6427W
Real Estate Credit Investments Ltd
27 April 2021
 

27 April 2021

 

Real Estate Credit Investments Limited

 

Company Update Presentation

 

Real Estate Credit Investments Limited ("RECI" or "the Company") is pleased to advise investors of the release of its latest Company Update Presentation.

 

Given the ongoing uncertainty evolving from the COVID-19 pandemic, RECI's Investment Manager has prepared the Company Update Presentation to provide investors with:

 

 

an update of the position of the Company as at 31 March 2021;

a detailed review of the portfolio investments held by the Company; and

detail of the Company's strategy with regards to dividends, leverage, liquidity and opportunities in the UK and European real estate credit markets.

 

The Company is pleased to announce that the Company Update Presentation is now available on the Company's website at:

 

https://www.recreditinvest.com/investors/results-reports-and-presentations/#currentPage=1

 

An extract from the Summary section of the Company Update Presentation is set out for investors in the Appendix to this announcement.

 

For further information, please contact:

 

Broker: Richard Crawley / Richard Bootle (Liberum Capital) +44 (0)20 3100 2222

Investment Manager: Richard Lang (Cheyne) +44 (0)20 7968 7328

 

 

 

Appendix: Company Update Presentation Extract

 

Summary: The Investment Opportunity

 

· Attractive returns from low LTV credit exposure to UK and European commercial real estate assets

o Weighted Average LTV of 64.9% as at 31 March 2021

o Predominantly large, well capitalised, and experienced institutional borrowers

· Quarterly dividends delivered consistently since October 2013

o The Company has consistently sought to pay a stable quarterly dividend

o This has led to a stable annualised dividend of around 7% of NAV

o Maintaining dividend policy for March 2021 year end as announced in May 2020

· Highly granular book

o 61 positions

o Top position: 14.1% of NAV (by commitment) as at 31 March 2021

· Transparent and conservative leverage

· Access to established real estate investment team at Cheyne, which manages over $4bn AUM

· Access to pipeline of enhanced return investment opportunities identified by Cheyne

· Robust mitigation against a rising rates environment

o A high yielding portfolio, combined with a short weighted average life of 1.9 years, ensures minimal exposure to yield widening and the ability to redeploy quickly at higher rates

 

Summary: Responding to COVID

 

· Market

o Due to banks still not lending, Cheyne has become a "go to" lender

· Portfolio

o No defaults due to robust positions. Move to more senior positions

o Mark to Market recovery of 4.1p to NAV since initial COVID-19 impact in March 2020

· Cash

o Cash reserves maintained at between 5% to 10% of NAV

· Dividend

o Dividends maintained at 3.0p per quarter, 8.8% yield, based on share price, as at 31 March 2021

· Discount

o Average discount during 2021 calendar year to date of 6.4%, from >40% at peak

· Opportunities

o Increased returns at more defensive LTVs

 

Summary: Structural Strength - Positioned to Capitalise on Opportunities

 

· Having successfully navigated through the challenges posed by the COVID-19 pandemic, RECI is well positioned to address future market uncertainty, with a strong portfolio profile and modest leverage comprising:

o Senior loans and bonds equal to 82% of NAV

o Weighted average LTV of 64.9%

o The portfolio is concentrated on credits to large, well capitalised and experienced institutional borrowers

o Leverage of 1.23x gross (1.16x net of cash held) as at 31 March 2021

o Cash on balance sheet of £22.8m

· The Company has good visibility on its liquidity and income profile for the next financial year ending March 2022, and beyond

· The Company is positioned to take advantage of a new pipeline of opportunities from a position of strength

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGZGZDNVRGMZM
Date   Source Headline
18th May 20267:00 amRNSFact Sheet Announcement
29th Apr 20267:00 amRNSFact Sheet Announcement
31st Mar 20267:00 amRNSUpdate on Buyback Programme
20th Mar 20263:51 pmRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSFact Sheet Announcement
17th Mar 20267:00 amRNSFact Sheet Announcement
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20265:41 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
26th Feb 202612:30 pmRNSDividend Declaration Update
18th Feb 20263:51 pmRNSDividend Declaration
16th Feb 20267:00 amRNSFact Sheet Announcement
20th Jan 20267:00 amRNSFact Sheet Announcement
14th Jan 20269:30 amRNSDirectorsTalk Interview
19th Dec 20257:00 amRNSFact Sheet Announcement
19th Dec 20257:00 amRNSFact Sheet Announcement
10th Dec 202510:37 amRNSDirector/PDMR Shareholding
4th Dec 20255:47 pmRNSDirectorsTalk Interview
4th Dec 202512:59 pmRNSDirector/PDMR Shareholding
27th Nov 20257:01 amRNSDividend Declaration
27th Nov 20257:00 amRNSHalf-year Financial Report
20th Nov 20257:00 amRNSFact Sheet Announcement
27th Oct 20257:00 amRNSShare Buyback Programme in a Closed Period
24th Oct 20257:00 amRNSFact Sheet Announcement
30th Sep 20257:00 amRNSExtension of Buyback Programme
17th Sep 20253:45 pmRNSDividend Declaration
17th Sep 20253:13 pmRNSResult of AGM
12th Sep 20257:00 amRNSFact Sheet Announcement
4th Sep 20253:58 pmRNSPostponement of RECI Investor Day
26th Aug 20253:34 pmRNSDirector/PDMR Shareholding
19th Aug 20257:00 amRNSFact Sheet Announcement
12th Aug 20257:00 amRNSNotice of AGM
28th Jul 20257:00 amRNSRECI Investor Day - 8 September 2025
15th Jul 20257:00 amRNSFact Sheet Announcement
25th Jun 20257:00 amRNSDividend Declaration
25th Jun 20257:00 amRNSAnnual Financial Report
11th Jun 20257:00 amRNSFact Sheet Announcement
21st May 20255:18 pmRNSDirector Declaration - Additional Directorship
19th May 20257:00 amRNSFact Sheet Announcement
17th Apr 20257:00 amRNSFact Sheet Announcement
8th Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20253:30 pmRNSFurther Buyback Programme
20th Mar 20251:32 pmRNSDirector/PDMR Shareholding
17th Mar 20257:00 amRNSFact Sheet Announcement
14th Mar 20254:34 pmRNSDirector/PDMR Shareholding
19th Feb 20252:59 pmRNSDividend Declaration
14th Feb 20257:00 amRNSFact Sheet Announcement
22nd Jan 20257:00 amRNSFact Sheet Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.